Home
>
USA
>
Investors
> ASX Announcements
Print Page
Email Page
RSS Feeds
Email Alerts
IR Contacts
ASX Announcements
Receive Email Alerts
|
RSS Feeds
Keyword Search
2010
|
2009
|
2008
|
2007
|
2006
Date
Title
09/06/10
Option Exercise - ASX Appendix 3B
09/06/10
FDA Grants HeartWare Second Patient Allotment Under CAP
08/19/10
Option Grant - ASX Appendix 3B
08/19/10
Option Exercise - ASX Appendix 3B
08/12/10
HeartWare Study to be Late-Breaker at American Heart Assn.
08/09/10
Appendix 4D and Half Year Financial Statements (US GAAP)
08/06/10
HeartWare Announces Second Quarter Results
08/05/10
HeartWare to Present at Canaccord Growth Conference
07/30/10
HeartWare to Present at Wedbush Best Ideas Conference
07/28/10
Second Quarter Earnings Release Call
07/07/10
Amended ASX Appendix 3Bs
07/02/10
Option Exercise - ASX Appendix 3B
07/02/10
Option Grant - ASX Appendix 3B
06/25/10
Announces Board Succession
06/18/10
HeartWare to present at Wells Fargo
06/18/10
Exercise of Options - ASX Appendix 3B
06/15/10
HeartWare To Commence Destination Therapy Trial
06/07/10
Exercise and Cancellation of Options
05/07/10
Change of Director`s Interest Notices
05/05/10
Annual General Meeting Results
05/05/10
Grant of Incentive Equity - Appendix 3B
05/05/10
Annual General Meeting Materials
05/05/10
Appendix 3B
05/05/10
First Quarter 2010 Financial Statements
05/04/10
First Quarter Results
05/03/10
Appendix 3B
04/27/10
Initiates voluntary repairs and recalls certain controllers
04/27/10
First 100 Patient Commercial and Clinical Data
04/12/10
Heartware to Report Financial Results First Quarter of 2010
04/12/10
Notice of Annual General Meeting
04/08/10
FDA Approves Continued Access Protocol for BTT
03/26/10
Amended ASX Appendix 3B
03/24/10
Change of Director`s Interest Notice
03/24/10
Appendix 3B - Exercise of Stock Options
03/05/10
HeartWare to Present at Annual Roth Growth Conference
03/03/10
Grant and Cancellation of Equity - ASX Appendix 3B
03/03/10
Change of Director's Interest Notice
03/03/10
Appendix 3B - Vesting of Preformance Rights
02/24/10
Annual Report for 2009 and ASX Appendix 4E
02/23/10
Reports Q4 Rev. of US$12.2M and Annual Rev. of US$24.2M
02/23/10
Enrollment of US Bridge to Transplant Trial Completed
02/09/10
Fourth Quarter and Annual Results for 2009 Earnings Call
02/03/10
Completion of US$62 million Capital Raising
02/03/10
Capital Raising - Cleansing Notice
02/03/10
Capital Raising - ASX Appendix 3B Allotment
02/01/10
Exercise and Cancellation of Options
01/28/10
Pricing of Public Offering of Common Stock
01/27/10
Prospectus for Public Offering of HeartWare Common Stock
01/27/10
Public Offering of HeartWare Common Stock
01/12/10
Shareholder Update
01/04/10
Thoratec Loan Facility Update
12/10/09
Exercise of Options - Appendix 3B
12/08/09
Change of Director's Interest Notice
12/02/09
Exercise of Expiring Incentive Options
11/24/09
HeartWare files IDE for Destination Therapy
11/23/09
Change of Director's Interest Notice
11/23/09
Exercise of (Expiring) Options
11/17/09
Change of Director`s Interest Notices
11/17/09
Exercise of Options - ASX Appendix 3B
11/10/09
Change of Contact Details for HeartWare
11/09/09
CEO Presenting at Investment Conferences
11/06/09
HeartWare to Present at Upcoming Investment Conferences in November
11/05/09
Revenues of US$7.5M for Quarter Ended 30 September 2009
11/05/09
Financial Statements for September 30, 2009
10/29/09
Advance Notice of Q3 Earnings Call
10/27/09
Capital Raising Allotment - ASX Appendix 3B
10/27/09
Stockholder Meeting Results - Capital Raising Approved
10/27/09
Cleansing Notice for Capital Raising
10/06/09
FDA Approves Expansion to 40 Sites for US BTT Trial
10/05/09
Exercise of Incentive Options
09/23/09
Notice of Special Meeting of Stockholders - Capital Raising
09/21/09
Annual Employee Equity Allocation
09/21/09
Exercise and Cancellation of Options
09/07/09
Option Exercise and Cancellations
09/02/09
Reinstatement to Official Quotation
09/02/09
Half Yearly Report / Accounts and Review Report
08/21/09
HeartWare Surpasses 50 US Implants
08/18/09
Cleansing Notice for US$60 Miliion Placement
08/18/09
Closes US$60 Million Placement
08/17/09
ASX Appendix 4D And Half Year Financial Statements (US GAAP)
08/11/09
US$55 Million Capital Raising
08/03/09
Joint Termination of Merger
07/31/09
Change of Directors Interests - Annual Meeting Stock Issue
07/31/09
Issue of Stock Pursuant to Annual Meeting Approval
07/31/09
Quarterly Update And ASX Appendix 4C
07/30/09
Annual Meeting Results
07/30/09
US FTC to Challenge Thoratec Acquisition of HeartWare
07/30/09
Trading Halt
07/30/09
Annual Meeting Materials
07/29/09
Annual Meeting to be Webcast
07/21/09
Change of Interests in Securities for Executive Director
07/06/09
Appendix 3B - Vesting of RSUs
07/02/09
Appendix 3B
06/18/09
Appendix 3B
06/17/09
Revised Thoratec Merger Documentation
06/12/09
Notice of Annual General Meeting/Proxy Form
05/12/09
CEO Presenting at JMP Securities Research Conference
05/12/09
Quarterly Financial Statements 31 March 2009
05/11/09
Thoratec Files Registration Statement
05/08/09
Thoratec Files Registration Statement
04/30/09
Quarterly Update April 2009 and ASX Appendix 4C
04/24/09
European Clinical Data Update
03/31/09
First International Sales of HeartWare® Ventricular Assist System and US Clinical Trial Enrolment Update
03/27/09
Thoratec and HeartWare Receive Request for Additional Information from US. Federal Trade Commission
03/18/09
Appendix 3B
02/27/09
2008 Annual Financial Report
02/27/09
2008 Preliminary Final Report
02/20/09
NASDAQ Listing Confirmation
02/19/09
HeartWare to be Acquired By Thoratec Corporation for US$282
02/18/09
Additional Merger Documentation
02/16/09
HeartWare to be Acquired By Thoratec Corporation for US$282
02/13/09
Trading Halt
02/10/09
First Implants at Northwestern Memorial
02/06/09
Co-PI Appointed for US Clinical Trial
01/30/09
Quarterly Report and CEO Letter
01/30/09
CE Mark Approval received
01/13/09
J P Morgan Healthcare Conference Presentation
12/31/08
Cancellation of Options
12/17/08
Principal Investigator Appointed for US Clinical Trial
12/05/08
Enrollment of International Trial Completed
12/04/08
NASDAQ Dual Listing Filing
11/20/08
MVAD & HVAD Update
11/20/08
2nd US Clinical Site Commences Implants
11/18/08
CEO Healthcare Conference Presentations
11/07/08
Initial Directors Interest Notice
11/05/08
HeartWare Group Redomiciliation and Trading of CDIs
11/03/08
Date of Allotment of CDI Securities
11/03/08
Indicative Top 20 Holders
11/03/08
Admission to the Official List
11/03/08
Lodgement of Court Orders with ASIC
10/31/08
Quarterly Update And ASX Appendix 4C
10/30/08
Federal Court Approval of Schemes of Arrangement
10/24/08
Cleveland Clinic Presentation
10/22/08
Redomiciliation Meeting Materials
10/22/08
Redomiciliation Meeting Results
10/20/08
Awarded ISO Certification
10/15/08
Medical Conference Presentations
10/03/08
Non-Executive Director Appointed
10/03/08
Initial Directors Interest Notice
09/25/08
Cancellation of Options
09/23/08
FDA Grants Full IDE Approval in the United States
09/22/08
Redomiciliation Documents Dispatched to Shareholders
09/17/08
Federal Court Approval for Scheme Meetings for Redomiciliation
09/15/08
Change of Directors Interests
09/11/08
CE Mark Submission
09/08/08
Change of Directors Interest
09/04/08
Change of Share Registry
09/03/08
Cancellation of Options
09/03/08
Change of Directors Interests
09/03/08
Change of Directors Interests
08/28/08
Change of Directors Interests
08/27/08
Change of Directors Interests
08/26/08
Change of Directors Interests
08/25/08
Change of Directors Interests
08/22/08
Change of Directors Interests
08/21/08
First U.S. Implant
08/19/08
Change of Directors Interests
08/14/08
Annual Equity Award
08/14/08
Change of Directors Interests
08/13/08
Half-Year Financial Report 30 June 2008
08/12/08
Canaccord Adams Presentation
08/12/08
Canaccord Adams Presentation
08/12/08
Canaccord Adams Presentation
08/05/08
Proposed Redomiciliation in the United States
08/01/08
First IRB Approval in the United States
07/31/08
Quarterly Update and Appendix 4C
07/25/08
Redemption of Convertible Note
07/11/08
Change of Directors Interests - Placement
07/11/08
Grant of Options to Non Executive Director
07/11/08
Completion of Placement A$31M
07/11/08
Results of EGM
07/11/08
EGM Materials
06/20/08
Cancellation of Options
06/11/08
SPP Cancelled
06/04/08
Notice of Extraordinary General Meeting
05/27/08
Shareholder Share Purchase Plan Update
05/26/08
Preliminary Notice of Meeting - EGM
05/23/08
Private Placement in Excess of A$30 Million
05/16/08
Operational Update
05/09/08
2008 Annual General Meeting
05/09/08
Results of Annual General Meeting 2008
05/09/08
Grant of Performance Rights
05/09/08
Change of Directors Interest
05/08/08
Change of Directors Interests
05/06/08
Change of Directors Interests
05/05/08
FDA grants conditional IDE approval
05/02/08
Change of Directors Interest
04/30/08
Non-Executive Director Appointed
04/30/08
Quarterly Update And ASX Appendix 4C
04/29/08
Chief Medical Officer Appointe
04/18/08
New Manufacturing Facility
04/18/08
2007 Annual Report
04/14/08
Clinical Data for First 23 Patients
04/14/08
Clinical Data for First 23 Patients
04/09/08
Notice of Annual General Meeting 2008
03/26/08
Draft Notice of Annual General Meeting 2008
03/26/08
Cancellation of Employee Share Options
03/04/08
30th Patient - Survival Update
02/29/08
2007 ASX Appendix 4E - Preliminary Final Report
02/29/08
2007 Annual Financial Report And Directors Report
02/29/08
2007 US Annual Report (US GAAP)
02/06/08
Change of Directors Interest
02/05/08
Change of Directors Interest
01/31/08
Quarterly Update & 4C
01/27/08
Incentive Option Terms for Non-Exec.Directors & Inteq Ltd
12/19/07
Shareholder Update
12/13/07
Appendix 3B - ESOP
12/04/07
Change of Address of Share Registry
11/20/07
Performance Rights and ESOP Grant
11/20/07
Appendix 3B - ESOP
11/20/07
Appendix 3B - Incentive Options
11/02/07
Presentation at ISRBP Conference
11/01/07
Submission to FDA for Investigational Device Exemption (IDE)
10/31/07
Quarterly Update And ASX Appendix 4C
09/03/07
Completion of Enrolment in International Clinical Trial
08/31/07
Interim Financial Report 30 June 2007
08/21/07
Change of Directors Interest
08/15/07
US GAAP Financial Statements - Quarter Ended 30 June 2007
08/07/07
Participant Bulletin
07/31/07
Quarterly Update And ASX Appendix 4C
07/26/07
EGM Presentation Materials
07/26/07
Results of EGM
07/26/07
Private Placement Complete
07/26/07
Change of Directors Interest
07/26/07
Grant of Options Under ESOP
07/26/07
Change of Directors Interest
07/26/07
Change of Directors Interest
07/24/07
First Recovery Patient
07/24/07
Share Purchase Plan Closed
07/19/07
Dual Reporting Requirements
07/17/07
Updated Registration Statement on Form 10 - US GAAP Financials
07/13/07
Clinical Trial Update - July 2007
07/10/07
Change of Address
07/04/07
Change of Directors' Interest
07/03/07
Change of Directors Interest
06/27/07
Notice of EGM
06/26/07
Share Purchase Plan
06/14/07
Private Placement in Excess of $30 Million
05/24/07
Annual General Meeting Confirmation
05/23/07
Annual General Meeting Materials
05/23/07
Results of Annual General Meeting
05/01/07
HeartWare Moves Towards NASDAQ Listing
04/30/07
Quarterly Update And ASX Appendix 4C
04/20/07
Annual Report & Notice of AGM
04/20/07
Cancellation of ESOP Options
04/11/07
First Implant at St Vincent's
04/03/07
Ethics Committee Approval at St Vincent's Hospital
04/02/07
Fourth Implant Centre Opened
03/22/07
One Year Anniversary of First Implant
03/13/07
Shareholder Update
03/13/07
CEO Presentation
02/28/07
ASX Appendix 4E 31 December 2006
02/28/07
2006 Annual Financial Report and Directors' Report
01/31/07
Quarterly Update & ASX Appendix 4C
01/18/07
End of Restriction Period
01/18/07
Appendix 3B - Exercise of ESOP Options
01/10/07
First Implant at Hannover Medical Centre
01/03/07
Grant of Options under ESOP
01/03/07
Letter to Shareholders
01/03/07
Change of Directors Interest
12/11/06
Appointment of Non Executive Director
11/29/06
CEO Presentation November 2006
11/29/06
Change of Directors Interests
11/22/06
Executive Appointment & 5th Implant
11/20/06
Change of Directors Interest
11/06/06
Change of Directors Interest
10/31/06
Quarterly Report
10/31/06
Appointment of Executive Director
10/31/06
Grant of Options
10/23/06
First Implant at Royal Perth
10/23/06
ASX Appendix 3B
10/18/06
Change of Directors Interest
10/11/06
Letter to Shareholders
10/10/06
Change of Directors Interest
10/10/06
Change of Directors Interest
10/04/06
Appendix 3B
10/03/06
Change of Directors Interest
09/14/06
Change of Directors Interest
09/04/06
Appointment of New Chief Executive Officer
07/31/06
2006 Interim Financial Report
07/31/06
Quarterly Cash Flow June 2006
07/26/06
ESOP Grant
07/07/06
German Regulatory Approval
07/06/06
Clarification of Option Cancellation
07/05/06
ASX Appendix 3B
06/20/06
Change of Directors Interest
06/19/06
Change of Directors Interest
06/16/06
Change of Directors Interest
06/16/06
Closing of HeartWare SPP
06/15/06
Presentation at the Australian Biotechnology Expo
06/13/06
Change of Directors Interest
05/23/06
2006 Annual General Meeting Presentation
05/23/06
Annual General Meeting Results
05/23/06
Completion of Capital Raising
05/22/06
Regulatory Approval in the United Kingdom
05/19/06
HeartWare Shareholder Share Purchase Plan
05/15/06
Change of Directors Interest
05/11/06
Change of Directors Interest
05/10/06
$32.5 Million Capital Raising
04/28/06
Clinical Trial Update - April 2006
04/21/06
Chief Operating Officer Appointed
04/20/06
Annual Report 2005 and Notice of Annual General Meeting
04/20/06
ASX Appendix 4C Quarter Ended 31 March 2006
03/27/06
Annual Financial Report and Directors Report 31 Dec 2005
03/24/06
Clinical Trials Commence
03/15/06
Change of Directors Interests
03/08/06
TGA Approval
02/28/06
ASX Appendix 4E
01/31/06
ASX Appendix 4C 31 December 2005
01/30/06
Removal of FORUS
01/24/06
Amended Director Interests
01/10/06
End of Restriction Period
01/05/06
Regulatory Approval
01/03/06
Initial Substantial Shareholder Notice
12/15/05
Appendix 3B
12/01/05
Change of Directors Interest
12/01/05
ASX Appendix 3B
11/10/05
Settlement of Patent Dispute
11/02/05
Completion of Studies
10/19/05
Negotiations Commence
10/19/05
Quarterly Cash Flow
10/11/05
Advisory Board GLP Review
09/27/05
Change of Directors Interest
09/09/05
New Medical Advisory Board Appointee
09/06/05
Ventracor Litigation Announcement
09/06/05
Change of Address
08/31/05
MVAD
08/16/05
CEO Presentation
08/02/05
Defence and Counterclaim to Litigation
08/01/05
GLP Update
07/29/05
BIVAD Implant
07/25/05
Half Year Report
07/25/05
ASX Appendix 4C
07/22/05
Shareholder Update
07/01/05
Change of Directors Interest
07/01/05
Appendix 3B
05/27/05
Change of Director's Interest Notice
05/23/05
Appendix 3B - Exercise of Options
05/03/05
New Executive Appointments & Appendix 3B
03/17/05
VCR release re claims on VCR's ASX announcement platform
03/16/05
Shareholder Update
03/10/05
Change of Director's Interest Notice
03/04/05
Appointment of Chief Financial Officer
03/04/05
Change of Director's Interest Notice
02/22/05
Change of Director's Interest Notice
02/15/05
Change of Director's Interest Notice
02/10/05
Granted first European Patent
02/08/05
Change of Director's Interest Notice
02/08/05
Amended Appendix 3X - Initial Director's Interest Notice
02/07/05
Change of Director's Interest Notice x2
02/02/05
Change of Director's Interest Notice x2
02/01/05
Initial Director's Interest Notice x5
01/28/05
Correction to Admission to Official List-Issue Price Amended
01/27/05
Constitution
01/27/05
Appendix 1A - ASX Listing Application & Agreement
01/27/05
Convertible Note Terms
01/27/05
Employee Share Option Plan
01/27/05
Statement of Commitments
01/27/05
Top 20 Holders
01/27/05
Escrow Statement
01/27/05
Distribution Schedule
01/27/05
Company's Letter to Australian Stock Exchange
01/27/05
Pre-Quotation Disclosure
01/27/05
Admission to Official List
01/27/05
Circular to Participating Organisations - Regulation S
01/27/05
Circular re Commencement of Official Quotation
01/17/05
Disclosure Document
12/17/04
Prospectus
Copyright © HeartWare International, Inc.
Legal Disclaimer
|
Contact Us